发明名称 |
Integrated insulin delivery system with continuous glucose sensor |
摘要 |
Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated. |
申请公布号 |
US9572936(B2) |
申请公布日期 |
2017.02.21 |
申请号 |
US201314063790 |
申请日期 |
2013.10.25 |
申请人 |
DexCom, Inc. |
发明人 |
Dobbles John Michael;Kamath Apurv Ullas;Mahalingam Aarthi;Brauker James H. |
分类号 |
A61M5/172;A61B5/145;A61M5/142;G06F19/00;A61B5/00;A61M5/00;A61M5/178;A61M5/30;A61M11/00;A61M15/00 |
主分类号 |
A61M5/172 |
代理机构 |
Knobbe Martens Olson & Bear, LLP |
代理人 |
Knobbe Martens Olson & Bear, LLP |
主权项 |
1. An integrated system for monitoring a glucose concentration in a host and for delivering insulin to the host, the system comprising:
a continuous glucose sensor, wherein the continuous glucose sensor is configured to substantially continuously measure a glucose concentration in a host, and to provide sensor data associated with the glucose concentration of the host; an electronics module comprising a bolus controller module configured to iteratively determine an insulin therapy instruction in response to an evaluation of a relationship of internally derived data and an engageable bolus constraint, wherein a relationship of internally derived data to the bolus constraint is evaluated in response to engagement of the bolus constraint, and wherein the bolus constraint comprises a maximum total insulin dose that can be delivered within a predefined time period in response to engagement of the bolus constraint; and an insulin delivery device configured to deliver insulin to the host, wherein the insulin delivery device is at least one of physically connected to a receiver and/or operably connected to a receiver, and wherein the insulin delivery device is configured to receive the insulin therapy instruction from the controller module. |
地址 |
San Diego CA US |